|
End-of-day quote
Shanghai S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 17.36 CNY | -1.70% |
|
-3.07% | -1.48% |
| 01:33pm | DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +39.86% | 7 | ||||||
| 58.58 | +76.22% | 16 | ||||||
| 4.606 | +64.79% | 15 | ||||||
| 3,035 | +17.98% | 10 | ||||||
| 33.09 | +38.27% | 12 | ||||||
| 121.52 | +30.03% | 9 | ||||||
| 327.88 | +56.87% | 8 | ||||||
| - | - | 1,415 | +214.1% | 1 | ||||
| 48.83 | +28.75% | 6 | ||||||
| 37.19 | +28.23% | 8 | ||||||
| 86.1 | +39.1% | 10 | ||||||
| 14.86 | +28.01% | 5 | ||||||
| 52.7 | +35.13% | 8 | ||||||
| 1,013.14 | +46.93% | 7 | ||||||
| - | 92.5 | +24.75% | 2 | |||||
| - | 5,100 | +36.36% | 2 | |||||
| Average | 716.61 | +50.34% | 8 | ||||||
| Weighted average by Cap. | 557.26 | +57.92% | 11 |
Select your edition
All financial news and data tailored to specific country editions
